These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 7780096

  • 1. In vitro activities of 2,2'-bipyridyl analogues against Mycobacterium avium and M. tuberculosis.
    Dhople AM, Dhople AA, Ibanez MA.
    Tuber Lung Dis; 1995 Apr; 76(2):136-40. PubMed ID: 7780096
    [Abstract] [Full Text] [Related]

  • 2. In vitro activities of 2,2'-bipyridyl analogs against Mycobacterium leprae.
    Dhople AM, Ibanez MA, Dhople AA.
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2908-9. PubMed ID: 7695282
    [Abstract] [Full Text] [Related]

  • 3. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates.
    Foroumadi A, Soltani F.
    Boll Chim Farm; 2003 Dec; 142(6):248-50. PubMed ID: 14606264
    [Abstract] [Full Text] [Related]

  • 4. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
    Koga T, Fukuoka T, Doi N, Harasaki T, Inoue H, Hotoda H, Kakuta M, Muramatsu Y, Yamamura N, Hoshi M, Hirota T.
    J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
    [Abstract] [Full Text] [Related]

  • 5. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
    Foroumadi A, Soltani F, Moshafi MH.
    Boll Chim Farm; 2002 Oct; 141(5):394-6. PubMed ID: 12481384
    [Abstract] [Full Text] [Related]

  • 6. Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis.
    Heifets LB, Iseman MD, Lindholm-Levy PJ.
    Antimicrob Agents Chemother; 1986 Dec; 30(6):927-32. PubMed ID: 3101588
    [Abstract] [Full Text] [Related]

  • 7. Comparison of bacteriostatic and bactericidal activity of isoniazid and ethionamide against Mycobacterium avium and Mycobacterium tuberculosis.
    Heifets LB, Lindholm-Levy PJ, Flory M.
    Am Rev Respir Dis; 1991 Feb; 143(2):268-70. PubMed ID: 1899326
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria.
    Dickinson JM, Mitchison DA.
    Tubercle; 1987 Sep; 68(3):177-82. PubMed ID: 2834842
    [Abstract] [Full Text] [Related]

  • 9. In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin.
    Woodley CL, Kilburn JO.
    Am Rev Respir Dis; 1982 Sep; 126(3):586-7. PubMed ID: 6289711
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Determination of in vitro susceptibility of mycobacteria to ansamycin.
    Heifets LB, Iseman MD.
    Am Rev Respir Dis; 1985 Sep; 132(3):710-1. PubMed ID: 3929660
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages.
    Crowle AJ, Elkins N, May MH.
    Am Rev Respir Dis; 1988 May; 137(5):1141-6. PubMed ID: 3143278
    [Abstract] [Full Text] [Related]

  • 13. MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs.
    Heifets L.
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1131-6. PubMed ID: 2461162
    [Abstract] [Full Text] [Related]

  • 14. Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
    Heifets LB, Lindholm-Levy PJ.
    Tubercle; 1987 Dec; 68(4):267-76. PubMed ID: 3138801
    [Abstract] [Full Text] [Related]

  • 15. Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis.
    Heifets LB, Lindholm-Levy PJ, Flory MA.
    Am Rev Respir Dis; 1990 Mar; 141(3):626-30. PubMed ID: 2155555
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [In vitro activities of rifabutine and rifampicin against various mycobacteria, especially Mycobacterium tuberculosis and Mycobacterium avium complex].
    Saito H, Sato K, Tomioka H.
    Kekkaku; 1988 Mar; 63(3):167-72. PubMed ID: 2836649
    [No Abstract] [Full Text] [Related]

  • 18. In Vitro Activity of 3-Triazeneindoles against Mycobacterium tuberculosis and Mycobacterium avium.
    Nikonenko BV, Kornienko A, Majorov K, Ivanov P, Kondratieva T, Korotetskaya M, Apt AS, Salina E, Velezheva V.
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6422-4. PubMed ID: 27503657
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro bactericidal activity of oxazolidinone, RBx 8700 against Mycobacterium tuberculosis and Mycobacterium avium complex.
    Rao M, Sood R, Malhotra S, Fatma T, Upadhyay DJ, Rattan A.
    J Chemother; 2006 Apr; 18(2):144-50. PubMed ID: 16736882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.